Results
1
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
1 companies
Vytrus Biotech
Market Cap: €117.3m
Vytrus Biotech, S.A. desarrolla, produce y comercializa principios activos a partir de células madre vegetales en España y a escala internacional.
VYT
€15.60
7D
-2.5%
1Y
164.4%